BioHealth News Archive
Pharma giants invest €23m in Bicycle – European Biotechnology News
Bicycle’s founding venture capitalist (VC), Atlas Ventures joined forces this month with SV Life Sciences and three corporate VCs – Novartis (NVS) Venture Fund,…
Read More
Illumina Admits First Startup Accelerator Class – Xconomy
Bioinformatics giant Illumina (NASDAQ: ILMN) is getting into the accelerator game, along with other players in the life sciences and other fields. On Wednesday…
Read More
CIT releases annual report on research commercialization in Virginia – Augusta Free Press
The Center for Innovative Technology (CIT) announced this week the release of the Commonwealth Research Commercialization Fund (CRCF) annual report for FY2014, showing growth in…
Read More
Tech Council of Maryland Awarded Three-Year Cyber Workforce Training Grant
The Tech Council of Maryland (TCM), Maryland’s largest technology trade association for life science and technology, has been awarded a three-year, $225,000 federal grant…
Read More
Sucampo Announces Extension of AMITIZA License and Collaboration Agreement With Takeda
Sucampo Pharmaceuticals has announced that it signed an amendment to the existing collaboration and license agreement (Collaboration Agreement) covering the United States and Canada…
Read More
First look at the $200M Maryland Proton Treatment Center in Baltimore – Baltimore Business Journal
University of Maryland, Baltimore’s $200 million proton therapy center will begin treating cancer patients in a year. The center’s first of five treatment rooms…
Read More
2014 Eastern Shore Business Competition
The Eastern Shore Entrepreneurship Center (ESEC), Rural Maryland Council (RMC), and Maryland Capital Entreprises (MCE) have joined together to offer the third annual Eastern Shore Business Competition.…
Read More
CASIS Announces Grant Awards for Enabling Technologies – CASIS – Center for the Advancement of Science in Space
The Center for the Advancement of Science in Space (CASIS) has announced grant awards for three projects focused on enabling technologies from the International…
Read More
DreamIt Health Baltimore Now Accepting Applications for 2015
The global accelerator DreamIt Ventures has announced that it is now accepting applications for DreamIt Health Baltimore, a four-month acceleration program based in one the…
Read More
Biotech’s Builder: How The Pharma’s Landlord Could Benefit From The Drug Boom
As the tech industry falls back in love with urban America, Joel Marcus, landlord to the booming biotechnology business, is perfectly positioned to strike…
Read More
Genomics England Names QIAGEN Bioinformatics One of the UK100K Project Assessment Winners
QIAGEN N.V. (NASDAQ: QGEN)(Frankfurt Prime Standard: QIA) announced today that its business area, QIAGEN Bioinformatics, has been named by Genomics England (GeL) an assessment…
Read More
Thanks to resistance, drug companies retiring antibiotic after antibiotic
Antibiotic resistance is taking its toll on the pharmaceutical industry: Drugs are getting retired from clinical circulation, because many are starting to get rendered…
Read More
UCSF-Developed Entrepreneurship Course for Life Scientists Launched by NIH – ucsf.edu
The National Institutes of Health (NIH) has launched a pilot program to help life science entrepreneurs commercialize their technology, based on a course developed…
Read More
Sitting in Chairs Most of the Day Can Kill You, But a Little Standing Can Bring Back Your Health – Scientific American
Chairs: we sit in them, work in them, shop in them, eat in them and date in them. Americans sit for most of their…
Read More
Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis)
Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and…
Read More